Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells
- PMID: 23936814
- PMCID: PMC3722883
- DOI: 10.1155/2013/535796
Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells
Abstract
Silver nanoparticles (AgNPs) have been used as an antimicrobial and disinfectant agents. However, there is limited information about antitumor potential. Therefore, this study focused on determining cytotoxic effects of AgNPs on MDA-MB-231 breast cancer cells and its mechanism of cell death. Herein, we developed a green method for synthesis of AgNPs using culture supernatant of Bacillus funiculus, and synthesized AgNPs were characterized by various analytical techniques such as UV-visible spectrophotometer, particle size analyzer, and transmission electron microscopy (TEM). The toxicity was evaluated using cell viability, metabolic activity, and oxidative stress. MDA-MB-231 breast cancer cells were treated with various concentrations of AgNPs (5 to 25 μg/mL) for 24 h. We found that AgNPs inhibited the growth in a dose-dependent manner using MTT assay. AgNPs showed dose-dependent cytotoxicity against MDA-MB-231 cells through activation of the lactate dehydrogenase (LDH), caspase-3, reactive oxygen species (ROS) generation, eventually leading to induction of apoptosis which was further confirmed through resulting nuclear fragmentation. The present results showed that AgNPs might be a potential alternative agent for human breast cancer therapy.
Figures
References
-
- Chan K, Morris GJ. Chemoprevention of breast cancer for women at high risk. Seminars in Oncology. 2006;33(6):642–646. - PubMed
-
- Jenal A, Thomas A, Murry T. Cancer stastics. CA: A Cancer Journal for Clinicians . 2002;52:23–37. - PubMed
-
- Johnston SRD. Acquired tamoxifen resistance in human breast cancer—potential mechanisms and clinical implications. Anti-Cancer Drugs. 1997;8(10):911–930. - PubMed
-
- Kato S, Endoh H, Masuhiro Y, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995;270(5241):1491–1494. - PubMed
-
- Lupu R, Cardillo M, Cho C, et al. The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Cancer Research and Treatment. 1996;38(1):57–66. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
